Aurobindo Pharma Subsidiary Invests $1M in US Arm

Aurobindo Pharma Ltd announced that its step-down subsidiary, A1 Biochem Labs (India) Private Limited, has subscribed to 10,000 equity shares of USD 100 each in A1 Biochem USA Inc. This investment totals USD 1,000,000 and was made on September 11, 2026. A1 Biochem USA Inc. is a newly incorporated entity in the USA, established on August 27, 2026, and will focus on Contract Research and Development services. This move is part of Aurobindo Pharma's earlier disclosed acquisition of the A1 Biochem Group. The subsidiary is wholly owned by A1 Biochem Labs (India) Private Limited, which is in turn a subsidiary of Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma.